Medicament for the prevention and / or treatment of atherosclerosis, medicaments for inhibiting vascular smooth muscle cell proliferation, neointimal formation of blood vessels and vascular remodeling, medicament for the prevention of restenosis following percutaneous coronary intervention, and, medicines for the prophylaxis and / or treatment of hypertension or diseases caused by hypertension or diseases caused by hypertension, heart disease, angina pectoris, myocardial infarction, arrhythmia, sudden death, heart failure, cardiac hypertrophy, kidney diseases, diabetic nephropathy, glomerulonephritis, nephrosclerosis, cerebrovascular diseases, cerebral infarction, and cerebral hemorrhage

摘要

"MEDICINAL PRODUCTS FOR THE PREVENTION AND / OR TREATMENT OF ARTERIOSCLEROSIS, MEDICINAL PRODUCTS FOR INHIBITION OF PROLIFERATION OF VASCULAR SLEEVE CELLS, FORMATION OF NEW BLOOD VESSELS AND REMODULATION OF THE CIRCULAR VASCULAR PRESSIONS , Drugs for the prophylaxis and / or treatment of hypertension or diseases caused by hypertension, heart disease, angina pectoris, arrhythmia disease, arrhythmia disease, cariathis disease, heart failure D DIABETIC NEPHROPATHY, GLOMERULONEPHRITIS, NEPHROSCLEROSIS, CEREBROVASCULAR DISEASES, CEREBRAL DISEASE, AND CEREBRAL HEMORRAGY ". A remedy for the prevention and / or treatment for atherosclerosis, hypertension, heart disease, kidney disease, or cerebrovascular disease. It comprises the following ingredients as active ingredients: (A) an angiotensin II receptor antagonist selected from the group consisting of the compound represented by the following formula (I), (I) pharmacologically acceptable esters thereof, and pharmacologically acceptable salts thereof (e.g. olmesartan medoxomil); and (B) a calcium antagonist selected from the group consisting of 1,4-dihydropyridine compounds and the pharmaceutically acceptable salts thereof (e.g. azelnidipine).